德菲洛克萨明通过降低MuRF1和阿特罗金-1来预防德克萨米他诱导的肌肉缩
Jae-Yeop Jeong1, Youngho Son1, Youngha Kim1
1Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Republic of Korea.
Frontiers in pharmacology
|July 24, 2025
概括
德福洛克萨明 (DFO) 通过恢复铁平衡和调节关键信号通路来预防德甲 (DEX) 诱导的肌肉缩. 这项研究表明,DFO.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 生理学 生理学 生理学
背景情况:
- 像德克萨米他 (DEX) 这样的葡萄糖皮质类药物通过无素-蛋白酶体系统诱导肌肉缩.
- 铁的不平衡越来越被认为是导致肌肉缩的因素.
研究的目的:
- 为了调查DEX是否会通过铁失衡引起肌肉缩.
- 为了确定铁化剂deferoxamine (DFO) 是否可以防止DEX诱导的肌肉缩.
主要方法:
- 在体外:用DEX和DFO处理的C2C12神经管,以评估缩标志物,铁含量和信号通路 (例如AKT,FOXO3a).
- 在体内:C57BL/6J小鼠接受DEX和DFO治疗,以评估肌肉功能,质量和纤维大小.
主要成果:
- 德克斯诱导的肌肉缩,细胞内铁的增加,以及上调的阿特罗金-1和MuRF1.
- 通过恢复铁平衡和调节AKT/FOXO3a和KLF15通路,DFO处理可以逆转这些影响.
- 在体内,DFO保留了DEX治疗小鼠的肌肉功能和质量.
结论:
- 德菲洛克萨明 (DFO) 有效地改善了德甲 (DEX) 诱导的肌肉缩.
- DFO通过恢复细胞内铁平衡和调节AKT/FOXO3a和KLF15信号来起作用.
- DFO显示出作为葡萄糖皮质醇诱导的肌肉缩的治疗剂的潜力.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
762
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
762
Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
Skeletal Muscle Relaxants: Adverse Effects
474
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
474
Skeletal Muscle Relaxants: Therapeutic Uses
618
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
618
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K


